Alkermes (ALKS) Work In Process (2011 - 2026)
Alkermes' (ALKS) quarterly Work In Process came in at $120.8 million in Q1 2026, up 62.86% year-on-year from $74.2 million in Q1 2025, and up 33.53% on a QoQ basis from $90.5 million in Q4 2025.
Alkermes (ALKS) Work In Process (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Work In Process data on file, last reported at $120.8 million in Q1 2026.
- On a quarterly basis, Work In Process rose 62.86% year-over-year to $120.8 million in Q1 2026; TTM through Mar 2026 was $120.8 million, a 62.86% increase from a year earlier, with the FY2025 full-year figure at $90.5 million, up 13.31% from the prior year.
- Work In Process for Q1 2026 stood at $120.8 million, up from $90.5 million in the prior quarter.
- Over the last five years, Work In Process for ALKS reached as high as $120.8 million in Q1 2026 and fell as low as $64.4 million in Q1 2022.
- Historically, Work In Process has averaged $78.9 million across 5 years, with a median of $76.2 million in 2022.
- Across the five-year window, Work In Process retreated 12.47% in 2024 and soared 62.86% in 2026, its largest moves.
- Year by year, Work In Process stood at $76.2 million in 2022, then fell by 9.69% to $68.8 million in 2023, then increased by 16.02% to $79.9 million in 2024, then climbed by 13.31% to $90.5 million in 2025, then jumped by 33.53% to $120.8 million in 2026.
- Per Business Quant data, the three most recent Work In Process figures were $120.8 million in Q1 2026, $90.5 million in Q4 2025, and $89.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.84 Mn |
| Dec 31, 2025 | 90.50 Mn |
| Sep 30, 2025 | 89.41 Mn |
| Jun 30, 2025 | 81.39 Mn |
| Mar 31, 2025 | 74.20 Mn |
| Dec 31, 2024 | 79.87 Mn |
| Sep 30, 2024 | 77.01 Mn |
| Jun 30, 2024 | 69.09 Mn |
| Mar 31, 2024 | 72.52 Mn |
| Dec 31, 2023 | 68.84 Mn |
| Sep 30, 2023 | 73.46 Mn |
| Jun 30, 2023 | 78.93 Mn |
| Mar 31, 2023 | 74.66 Mn |
| Dec 31, 2022 | 76.23 Mn |
| Sep 30, 2022 | 79.82 Mn |
| Jun 30, 2022 | 70.44 Mn |
| Mar 31, 2022 | 64.39 Mn |
| Dec 31, 2021 | 59.11 Mn |
| Sep 30, 2021 | 50.89 Mn |
| Jun 30, 2021 | 51.39 Mn |